AWP
WST icon

Accretive Wealth Partners’s West Pharmaceutical WST Stock Holding History

Accretive Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$972K Sell
2,708
-280
-9% -$85.6K 0.24% 88
2026
Q1 		$749K Buy
2,988
+22
+0.7% +$5.47K 0.21% 103
2025
Q4 		$816K Sell
2,966
-511
-15% -$140K 0.24% 91
2025
Q3 		$912K Buy
3,477
+191
+6% +$46.4K 0.28% 86
2025
Q2 		$719K Sell
3,286
-217
-6% -$46.4K 0.24% 99
2025
Q1 		$719K Buy
3,503
+616
+21% +$170K 0.25% 97
2024
Q4 		$946K Buy
+2,887
New +$909K 0.4% 82

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Accretive Wealth Partners's WST Position: Q2 2026 in Review

Accretive Wealth Partners reduced its West Pharmaceutical (WST) stake by 9.4% in Q2 2026, selling an estimated $85.6K and leaving 2,708 shares worth $972K. The position accounts for 0.24% of the portfolio, ranked #88.

Accretive Wealth Partners first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Accretive Wealth Partners held 2,708 shares of West Pharmaceutical worth $972K as of Q2 2026.
  • Accretive Wealth Partners sold 280 West Pharmaceutical shares in Q2 2026, an estimated $85.6K.
  • West Pharmaceutical made up 0.24% of Accretive Wealth Partners's portfolio in Q2 2026, its #88 holding.
  • Accretive Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Accretive Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.